Search

You searched for "implant"

1407 results found

The College of Optometrists: Optometry Tomorrow 2024 (incorporating BCLA Focus)

28 April 2024 -29 April 2024
by Claire McLoughlin, PR Manager, College of Optometrists, UK. The College of Optometrists and British Contact Lens Association (BCLA) welcomed around 900 attendees at Optometry Tomorrow 24 – now incorporating BCLA Focus – on 28–29 April. This was the 20th...

Fingolimod: ocular adverse effects

1 October 2017 | | Retina / Uvea / Vitreous
In this article the authors review the ocular side-effects of Fingolimod which is an oral immunomodulating drug used in the management of relapsing-remitting multiple sclerosis (RRMS). Fingolimod-associated macular oedema (FAME) is the most common ocular side-effect linked to this drug....

Telemedicine strategies in ophthalmology: harnessing established and emerging technologies for lasting solutions

7 December 2020 | | Ophthalmology, Retina / Uvea / Vitreous, Imaging, Oculoplastics
The author considers recent progress and shares insights from leading practitioners in telemedicine applications and digital technology strategies. Amidst COVID-19 and combined mitigation and suppression measures, hospitals and clinics have responded rapidly to strengthen telemedicine strategies and virtual healthcare services...
Clinical & Experimental Ophthalmology journal cover image

Atropine treatment for myopia in western countries – rationale

5 October 2020 | | Cataract and Refractive
This preliminary study sets out the rationale, methodology and participant baseline characteristics for the Western Australia Atropine for the Treatment of Myopia (WA-ATOM). It is a double masked randomised placebo-controlled trial. This study is designed to be combined with the...

Exciting opportunities for ophthalmic surgeons with the UK and Europe’s leading provider of cataract surgery, lens replacement surgery and laser eye surgery.

20 March 2023 | Recruitment & Personnel
We have opportunities across the UK and Ireland for ophthalmic surgeons to treat private pay, PMI and NHS funded patients.

Simon Lysaght joins Glaukos as Territory Manager, Ireland

28 June 2023 | Recruitment & Personnel
Glaukos Corporation is delighted to announce the appointment of Simon Lysaght to the position of Territory Manager, Ireland.

Optometry Today’s new education resource for practice teams

9 August 2023 | OT, AOP, Optometry Today, Optometry, Johnson & Johnson, Education, Training
Optometry Today (OT) has released a new education package for optometry practice teams, delivered in partnership with the Association of Optometrists (AOP) and Johnson & Johnson Vision.

Glaucoma UK and The Royal College of Ophthalmologists announce research award 2024

27 February 2024 | research, funding, grants, bursary, award, RCOphth, Glaucoma, UK, application
Glaucoma UK and The Royal College of Ophthalmologists are collaborating to run this prestigious award which has previously funded a range of research topics from prospective stem cell treatments to the use of big data in patient risk stratification.

The Eyes on Tomorrow Podcast

12 July 2024 | podcast, media, interview, conversation, eyes on tomorrow
So why would an ophthalmologist and an optometrist want to do a podcast together?

The value of hospital placements in ophthalmology in general practice specialty training

2 February 2024 | | Ophthalmology
Pratik Bikkannavar provides insights into the potential benefits a placement in ophthalmology provides General Practice Specialty Trainees (GPSTs) and its valuable purpose for the wider ophthalmic community. Ophthalmic complaints are known to account for up to 1 in every 20...

Cancelled eye surgeries could mean permanent sight-loss, warns Fight for Sight

4 June 2020
A survey by eye research charity Fight for Sight has found that people with sight loss fear their sight will further deteriorate during the Covid-19 pandemic, as they struggle to access treatment for their eye conditions.

Study reveals increase in Charles Bonnet Syndrome symptoms due to COVID-19

12 February 2021
A study published today in BMJ Open Ophthalmology has shown the impact of COVID-19 on those already experiencing vivid hallucinations as a result of Charles Bonnet syndrome (CBS).